Is Guided Antiplatelet Therapy Ready for Prime Time? – Davide Capodanno9 Marzo 2023Bridgining Antithrombotic Strategies in Patients with Coronary Stent Requiring Surgery – Giuseppe Musumeci9 Marzo 20230Vascular dose of rivaroxaban: from evidence to practice – Marco Ferlini<span data-mce-type="bookmark" style="display: inline-block; width: 0px; overflow: hidden; line-height: 0;" class="mce_SELRES_start"></span> Redazione ATBVPost associati15 Settembre 2023SPOTLIGHT SESSION: Repurposing Anti-Diabetic Drugs: Present and Future Use of Sodium-GLucose CoTransporter-2 Inhibitors and GLP-1 Receptor Agonists: Discussion and Take Home MessagesLeggi tutto15 Settembre 2023SGLT2i in Patients with Aterothrombosis, with and without heart failure – Stephen WiviottLeggi tutto15 Settembre 2023GLP-1 RA in Patients with Obesity – Angelo AvogaroLeggi tuttoComments are closed.
